IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION

The paper is focused on the results of a randomised clinical trial SHIFT, which started the discussion about the choice of optimal heart rate-lowering therapy in patients with chronic heart failure (CHF). The author summarizes the benefits of adding an If channel inhibitor ivabradine to the standard...

Full description

Bibliographic Details
Main Author:	Yu. M. Lopatin
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2012-08-01
Series:	Российский кардиологический журнал
Subjects:	chronic heart failure beta-blockers if channel inhibitor ivabradine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1238

Similar Items

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
by: Felix Memenga, et al.
Published: (2023-10-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Advances in the management of heart failure: the role of ivabradine
by: Müller-Werdan U, et al.
Published: (2016-11-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Looking for a Tailored Therapy for Heart Failure: Are We Capable of Treating the Patient Instead of the Disease?
by: Alessandro Fucili, et al.
Published: (2021-09-01)

The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model
by: S. V. Fedorov, et al.
Published: (2016-12-01)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study
by: Jingmin Zhou, et al.
Published: (2024-04-01)

Epidemiologic surveillance on quality of life in patients with systolic heart failure after treatment with the selective heart rate inhibitor ivabradine
by: M Srinivasa Rao, et al.
Published: (2017-01-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

The effect of ivabradine on hospitalization of heart failure patients: A retrospective cohort study
by: Sara Al-Balushi, et al.
Published: (2021-01-01)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
by: Teng-Yao Yang, et al.
Published: (2022-11-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
by: Yu‐Sheng Lin, et al.
Published: (2022-08-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01)

Practical Pharmacological Treatment of Heart Failure: Does Ejection Fraction Matter Anymore?
by: Jonathan C. H. Chan, et al.
Published: (2023-03-01)

ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01)

Observational study of new-onset atrial fibrillation in patients treated with Ivabradine alone versus Ivabradine and β-blocker drug (The BetaBrad Study)
by: Rohan S Thanedar, et al.
Published: (2022-01-01)

A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
by: David E. Lanfear, et al.
Published: (2020-08-01)

Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report
by: Holger Michel, et al.
Published: (2020-06-01)

Clinical Implications of Ivabradine in the Contemporary Era
by: Teruhiko Imamura
Published: (2024-02-01)

Ivabradine in patients with heart failure: a systematic literature review
by: Zeba M. Khan, et al.
Published: (2023-12-01)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
by: Amr Abdin, et al.
Published: (2023-10-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

Initiation of ivabradine in cardiogenic shock
by: Michael H. Chiu, et al.
Published: (2019-10-01)

Beneficial effect of ivabradine against cardiovascular diseases
by: Maria Alessandra Gammone, et al.
Published: (2020-03-01)

The effect of ivabradine therapy on dilated cardiomyopathy patients with congestive heart failure: a systematic review and meta-analysis
by: Juntao Yang, et al.
Published: (2023-10-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT‐AHF trial
by: Yang Su, et al.
Published: (2020-12-01)

Efficacy of ivabradin in combined treatment of patients with postinfarction systolic chronic cardiac failure
by: Anton Valer'evich Potapenko, et al.
Published: (2011-12-01)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
by: Tomoko Inoue, et al.
Published: (2023-03-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

Beta-blockers in chronic heart failure in elderly patient
by: Alberto De Bernardi
Published: (2009-06-01)